Cost-benefit analysis of the use of rhBMP-2 in open tibial fractures. Savings from a health insurer's perspective;Kosten-nutzen-betrachtung des einsatzes von rhBMP-2 bei offenen tibiafrakturen. Nettoeinsparungen aus krankenkassensicht erzielbar

Unfallchirurg

Volumn 109, Issue 6, 2006, Pages 463-470

  Alt, V ^a,b   Eicher, A ^a   Bitschnau, A ^a   Schnettler, R ^a  

^a UNIVERSITY HOSPITAL MARBURG   (Germany)

^b UNIVERSITY HOSPITAL GIESSEN   (Germany)

Author keywords

BMP 2; Fracture healing; Health economics; Tibia fracture

Indexed keywords

ARTICLE; CALCULATION; COST BENEFIT ANALYSIS; COST CONTROL; ECONOMIC ASPECT; FRACTURE HEALING; GERMANY; HEALTH INSURANCE; HUMAN; PATIENT CARE; PUBLICATION; TIBIA FRACTURE;

BONE MORPHOGENETIC PROTEINS; COST SAVINGS; COST-BENEFIT ANALYSIS; FRACTURE HEALING; GERMANY; HUMANS; INSURANCE, HEALTH; PROSPECTIVE STUDIES; RANDOMIZED CONTROLLED TRIALS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECOMBINANT PROTEINS; TIBIAL FRACTURES; TIME FACTORS; TRANSFORMING GROWTH FACTOR BETA; TREATMENT OUTCOME;

EID: 33745174845     PISSN: 01775537     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00113-006-1079-4     Document Type: Article

References (11)

1. Ackerman SJ, Mafilios MS, Polly DW Jr (2002) Economic evaluation of bone morphogenetic protein versus autogenous iliac crest bone graft in single-level anterior lumbar fusion: an evidence-based modeling approach. Spine 27 [16 Suppl 1]: 94-99
2. Bundesministerium für Gesundheit und Soziale Sicherung (2003) Leistungen der Gesetzlichen Krankenversicherung in Deutschland im Jahre 2003. Tabelle KJ 1 (http://www.bmgs.bund.de/downloads/kj12003.pdf) und Tabelle KG2 (http://www.bmgs.bund.de/downloads/KG2_96-03.pdf)
3. Court-Brown CM, Christie J, McQueen MM (1990) Closed intramedullary tibial nailing. Its use in closed and type I open fractures. J Bone Joint Surg Br 72(4): 605-611
4. Court-Brown CM, McQueen MM, Quaba AA, Christie J (1991) Locked intramedullary nailing of open tibial fractures. J Bone Joint Surg Br 73(6): 959-964
5. Court-Brown CM (2004) Reamed intramedullary tibial nailing: an overview and analysis of 1106 cases. J Orthop Trauma 18(2): 96-101
6. Eggli S, Scholl E, Hertel R (1998) Versorgung von IIIB offenen Unterschenkelfrakturen durch Frühosteosynthese und lokalen Muskellappen. Unfallchirurg 101(9): 674-683
7. Govender S, Csimma C, Genant HK et al. (2002) Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures: a prospective, controlled, randomized study of four hundred and fifty patients. J Bone Joint Surg Am 84(12): 2123-2134
8. Malik MH, Harwood P, Diggle P, Khan SA (2004) Factors affecting rates of infection and nonunion in intramedullary nailing. J Bone Joint Surg Br 86(4): 556-560
9. Polly DW Jr, Ackerman SJ, Shaffrey CI et al. (2003) A cost analysis of bone morphogenetic protein versus autogenous iliac crest bone graft in single-level anterior lumbar fusion. Orthopedics 26(10): 1027-1037
10. Sanders R, Jersinovich I, Anglen J et al. (1994) The treatment of open tibial shaft fractures using an interlocked intramedullary nail without reaming. J Orthop Trauma 8(6): 504-510
11. Udvarhelyi IS, Colditz GA, Rai A, Epstein AM (1992) Cost-effectiveness and cost-benefit analyses in the medical literature. Are the methods being used correctly? Ann Intern Med 116(3): 238-244